Aug 24, 2026 07:04AM
Aug 24, 2026 07:00AM
Aug 22, 2026 03:16PM
Aug 5, 2026 04:01PM
Jul 16, 2026 04:30PM
Jul 16, 2026 04:30PM
Jul 15, 2026 04:30PM NEREUS™ Powers Forward: Sponsors No. 47 IndyCar Entry, Celebrating 47 Years Since Last New U.S. Motion Sickness Treatment
Jul 9, 2026 06:51AM
Jul 7, 2026 04:31PM
Jul 7, 2026 04:30PM
Jun 4, 2026 06:42AM
May 6, 2026 04:01PM
May 4, 2026 08:02AM
May 4, 2026 08:00AM Vanda Pharmaceuticals Announces U.S. Commercial Availability of NEREUS™ (tradipitant), the First New Pharmacologic Treatment for People with Motion Sickness in More Than 40 Years
May 1, 2026 04:36PM
May 1, 2026 04:35PM
Apr 28, 2026 07:12PM
Apr 9, 2026 11:03AM
Apr 9, 2026 11:02AM
Apr 9, 2026 06:42AM
Apr 8, 2026 04:45PM Vanda starts trial of NEREUS drug for GLP-1 side effects
Apr 8, 2026 04:44PM
Mar 19, 2026 04:34PM
Mar 3, 2026 08:03AM
Mar 3, 2026 08:01AM
Feb 25, 2026 07:19AM
Feb 25, 2026 07:18AM
Feb 23, 2026 06:36AM Vanda Pharmaceuticals (VNDA) PT Raised to $24 at H.C. Wainwright
Feb 23, 2026 05:19AM
Feb 20, 2026 05:59PM
Feb 20, 2026 05:59PM
Feb 11, 2026 04:01PM
Jan 8, 2026 07:01AM
Jan 8, 2026 07:00AM
Jan 5, 2026 06:41AM Vanda Pharmaceuticals (VNDA) PT Raised to $22 at H.C. Wainwright
Dec 31, 2025 04:25AM
Dec 30, 2025 06:13PM
Dec 30, 2025 06:13PM
Dec 17, 2025 07:30AM
Dec 15, 2025 07:01AM
Dec 15, 2025 07:00AM
Dec 4, 2025 04:22PM FDA lifts clinical hold on Vanda's motion sickness drug tradipitant
Dec 4, 2025 04:21PM
Dec 1, 2025 06:35AM
Nov 28, 2025 07:00AM
Nov 28, 2025 07:00AM
Nov 17, 2025 06:37PM
Oct 29, 2025 04:01PM
Oct 2, 2025 06:45AM H.C. Wainwright Reiterates Buy Rating on Vanda Pharmaceuticals (VNDA)
Oct 1, 2025 05:03PM

330,533 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All